February 9, 2018 / 1:39 PM / 14 days ago

BRIEF-Aquinox Provides Enrollment Update For Leadership 301 Clinical Trial Of Rosiptor

Feb 9 (Reuters) - Aquinox Pharmaceuticals Inc:

* AQUINOX PROVIDES ENROLLMENT UPDATE FOR LEADERSHIP 301 CLINICAL TRIAL OF ROSIPTOR

* AQUINOX PHARMACEUTICALS INC - ENROLLMENT TARGET REACHED IN LEADERSHIP 301 CLINICAL TRIAL OF ROSIPTOR; TOPLINE DATA ON TRACK FOR Q3 2018 ANNOUNCEMENT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below